Literature DB >> 8202528

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

A C Alonso1, T Zaidi, I Grundke-Iqbal, K Iqbal.   

Abstract

The microtubule assembly-promoting activity of different pools of tau protein isolated from Alzheimer disease (AD) and control brains and the effect of dephosphorylation on this activity were studied. Tau isolated from a 2.5% perchloric extract of AD brain had almost the same activity as that obtained from control brain, and this activity did not change significantly on dephosphorylation. Abnormally phosphorylated tau (AD P-tau) isolated from brain homogenate of AD patients had little activity, and upon dephosphorylation with alkaline phosphatase, its activity increased to approximately the same level as the acid-soluble tau. Addition of AD P-tau to a mixture of normal tau and tubulin inhibited microtubule assembly. AD P-tau bound to normal tau but not to tubulin. These studies suggest that the abnormal phosphorylation of tau might be responsible for the breakdown of microtubules in affected neurons in AD not only because the altered protein has little microtubule-promoting activity but also because it interacts with normal tau, making the latter unavailable for promoting the assembly of tubulin into microtubules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202528      PMCID: PMC44036          DOI: 10.1073/pnas.91.12.5562

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

Authors:  I Grundke-Iqbal; K Iqbal; M Quinlan; Y C Tung; M S Zaidi; H M Wisniewski
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

2.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Detection of tubulin-binding proteins by an overlay assay.

Authors:  L Kremer; J E Domínguez; J Avila
Journal:  Anal Biochem       Date:  1988-11-15       Impact factor: 3.365

4.  Ultrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle.

Authors:  H M Wisniewski; P A Merz; K Iqbal
Journal:  J Neuropathol Exp Neurol       Date:  1984-11       Impact factor: 3.685

5.  Phosphorylation affects the ability of tau protein to promote microtubule assembly.

Authors:  G Lindwall; R D Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

6.  Decoration and stabilization of intact, smooth-walled microtubules with microtubule-associated proteins.

Authors:  R D Sloboda; J L Rosenbaum
Journal:  Biochemistry       Date:  1979-01-09       Impact factor: 3.162

7.  The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer.

Authors:  G C Ruben; K Iqbal; I Grundke-Iqbal; H M Wisniewski; T L Ciardelli; J E Johnson
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

8.  Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments.

Authors:  I Grundke-Iqbal; A W Vorbrodt; K Iqbal; Y C Tung; G P Wang; H M Wisniewski
Journal:  Brain Res       Date:  1988-08       Impact factor: 3.252

9.  Defective brain microtubule assembly in Alzheimer's disease.

Authors:  K Iqbal; I Grundke-Iqbal; T Zaidi; P A Merz; G Y Wen; S S Shaikh; H M Wisniewski; I Alafuzoff; B Winblad
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

10.  The distribution of tau in the mammalian central nervous system.

Authors:  L I Binder; A Frankfurter; L I Rebhun
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

View more
  241 in total

1.  Multiple forms of phosphatase from human brain: isolation and partial characterization of affi-gel blue binding phosphatases.

Authors:  L Y Cheng; J Z Wang; C X Gong; J J Pei; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

Review 2.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 3.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

Review 4.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

5.  Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Authors:  Krista L Lanctôt; Ryan D Rajaram; Nathan Herrmann
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

6.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

7.  Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.

Authors:  Michael Ditiatkovski; Nigora Mukhamedova; Dragana Dragoljevic; Anh Hoang; Hann Low; Tatiana Pushkarsky; Ying Fu; Irena Carmichael; Andrew F Hill; Andrew J Murphy; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

Review 8.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

9.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

10.  Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.

Authors:  Lata Rani; Jeetain Mittal; Sairam S Mallajosyula
Journal:  J Phys Chem B       Date:  2020-03-02       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.